TRACON PHARMS (TCON) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 127 251 sessions, December 1, 2023 to December 2, 2024
- Largest daily move
- +166.7% close of August 2, 2024
- 1-year change
- -99.2% closing prices, December 1, 2023 to December 2, 2024
Company Description
TRACON PHARMS (OTC: TCON) is classified in the biotechnology industry within the Healthcare sector.
TCON has declined 99.2% over the past year. The last closing price was $0.0322.
This page collects what Stock Titan holds for TCON, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TRACON PHARMS (TCON) closed at $0.0322 on December 2, 2024. Over the past 12 months, the price has lost 99.2%.
TCON Metrics & Rankings
Price returns through December 2, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
TRACON PHARMS has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, earnings, conferences, stock split. View all TCON news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TCON Company Profile & Sector Positioning
TRACON PHARMS (TCON) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TCON often look at related companies in the same sector, including GLOBESTAR THERAPEUTICS CO (GSTC), NDONOVO THERAPEUTICS INC (ENDV), PANBELA THERAPEUTICS INC (PBLA), TREVENA INC (TRVN), and VINCERX PHARMA INC (VINC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TCON's relative position within its industry.